AU3362895A - Use of zrk peptide sequences in contraception - Google Patents

Use of zrk peptide sequences in contraception

Info

Publication number
AU3362895A
AU3362895A AU33628/95A AU3362895A AU3362895A AU 3362895 A AU3362895 A AU 3362895A AU 33628/95 A AU33628/95 A AU 33628/95A AU 3362895 A AU3362895 A AU 3362895A AU 3362895 A AU3362895 A AU 3362895A
Authority
AU
Australia
Prior art keywords
zrk
contraception
peptide sequences
peptide
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33628/95A
Inventor
Deborah J Burks
Carl A Dowds
Lisette Leyton
Patricia M Saling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Publication of AU3362895A publication Critical patent/AU3362895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU33628/95A 1994-08-11 1995-08-10 Use of zrk peptide sequences in contraception Abandoned AU3362895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28911994A 1994-08-11 1994-08-11
US289119 1994-08-11
PCT/US1995/010166 WO1996005305A1 (en) 1994-08-11 1995-08-10 Use of zrk peptide sequences in contraception

Publications (1)

Publication Number Publication Date
AU3362895A true AU3362895A (en) 1996-03-07

Family

ID=23110141

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33628/95A Abandoned AU3362895A (en) 1994-08-11 1995-08-10 Use of zrk peptide sequences in contraception

Country Status (2)

Country Link
AU (1) AU3362895A (en)
WO (1) WO1996005305A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037663B2 (en) 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
EP1056858B1 (en) 1998-02-19 2004-12-08 Eastern Virginia Medical School RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3)
GB9926161D0 (en) * 1999-11-04 2000-01-12 Pig Improvement Company Uk Lim Methods
US7148021B2 (en) 2001-08-02 2006-12-12 Eastern Virginia Meical School Human zona pellucida proteins and methods of their use in diagnosing male infertility

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE175357T1 (en) * 1992-06-12 1999-01-15 Univ Connecticut CONTRACTIVE VACCINE

Also Published As

Publication number Publication date
WO1996005305A1 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
AU3850395A (en) Hemorrhoidal compositions and method of use
AU7383298A (en) Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
AU4484997A (en) Compositions containing cobalamin and amino acids
AU4266596A (en) Composition and use
AU4463996A (en) Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
AU1945395A (en) Use of xylanase in baking
AU3979395A (en) DNA sequences and their use
AU2054797A (en) Isolated human herpesvirus type 8 sequences and uses thereof
HU9700071D0 (en) Use of muramilpeptides
IL113992A0 (en) Use of copolymer-1
AU4236097A (en) Mhc peptides and methods of use
ZA96240B (en) Novel peptides their preparation and use
AU3634595A (en) Bis-oxazolidines and their use
AU3362895A (en) Use of zrk peptide sequences in contraception
ZA96239B (en) Novel peptides their preparation and use
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU5697996A (en) Peptidyl compounds and their therapeutic use
EP0754701A4 (en) Novel progesterone compound and use thereof
AU691690B2 (en) Acrolein-releasing composition and use thereof
AU4240596A (en) Compounding elements and use thereof
AU135502S (en) Condom
AU6092798A (en) Condom
AU5841696A (en) Preparation and use of contrast agents
AU1798100A (en) Use of peptide
AU7021694A (en) Secure enhancing condom